_version_ 1783244852721352704
author Ribi, Karin
Bernhard, Jürg
Luo, Weixiu
Regan, Meredith M.
Fleming, Gini F.
Francis, Prudence A.
author_facet Ribi, Karin
Bernhard, Jürg
Luo, Weixiu
Regan, Meredith M.
Fleming, Gini F.
Francis, Prudence A.
author_sort Ribi, Karin
collection PubMed
description
format Online
Article
Text
id pubmed-5477822
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher American Society of Clinical Oncology
record_format MEDLINE/PubMed
spelling pubmed-54778222017-07-01 Reply to F. Tomao et al Ribi, Karin Bernhard, Jürg Luo, Weixiu Regan, Meredith M. Fleming, Gini F. Francis, Prudence A. J Clin Oncol Correspondence American Society of Clinical Oncology 2016-12-01 2016-09-12 /pmc/articles/PMC5477822/ /pubmed/27621403 http://dx.doi.org/10.1200/JCO.2016.69.4158 Text en © 2016 by American Society of Clinical Oncology Licensed under the Creative Commons Attribution 4.0 License: http://creativecommons.org/licenses/by/4.0/
spellingShingle Correspondence
Ribi, Karin
Bernhard, Jürg
Luo, Weixiu
Regan, Meredith M.
Fleming, Gini F.
Francis, Prudence A.
Reply to F. Tomao et al
title Reply to F. Tomao et al
title_full Reply to F. Tomao et al
title_fullStr Reply to F. Tomao et al
title_full_unstemmed Reply to F. Tomao et al
title_short Reply to F. Tomao et al
title_sort reply to f. tomao et al
topic Correspondence
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5477822/
https://www.ncbi.nlm.nih.gov/pubmed/27621403
http://dx.doi.org/10.1200/JCO.2016.69.4158
work_keys_str_mv AT ribikarin replytoftomaoetal
AT bernhardjurg replytoftomaoetal
AT luoweixiu replytoftomaoetal
AT reganmeredithm replytoftomaoetal
AT flemingginif replytoftomaoetal
AT francisprudencea replytoftomaoetal